These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
114 related articles for article (PubMed ID: 4170552)
41. Sequential therapy to achieve anovulatory cycles. Oclander G Can Med Assoc J; 1966 Jan; 94(5):218-22. PubMed ID: 4159184 [TBL] [Abstract][Full Text] [Related]
42. Sequential approach to oral contraceptive therapy. Balin H; Wan LS; Rajan R Int J Fertil; 1969; 14(4):300-8. PubMed ID: 4186408 [No Abstract] [Full Text] [Related]
43. The effects of chlormadinone and mestranol on the formation of mammary tumours in Sprague-Dawley rats. Rieche K Rev Eur Etud Clin Biol; 1971 May; 16(5):458-62. PubMed ID: 4107067 [No Abstract] [Full Text] [Related]
44. [LH excretion during the ovulatory cycle and during therapy with various estrogen-gestagen combinations]. Göretzlehner G; Wilken H Endokrinologie; 1972 Nov; 60(3):302-8. PubMed ID: 4121480 [TBL] [Abstract][Full Text] [Related]
45. Two thousand woman-years' experience with a sequential contraceptive. A more effective method of taking a sequential contraceptive. Karrer MC; Smith ER Am J Obstet Gynecol; 1968 Dec; 102(7):1029-34. PubMed ID: 4177693 [No Abstract] [Full Text] [Related]
47. Effect of estrogen on the metabolism of metyrapone and release of ACTH. Meikle AW; Jubiz W; Matsukura S; Harada G; West CD; Tyler FH J Clin Endocrinol Metab; 1970 Feb; 30(2):259-63. PubMed ID: 4189881 [No Abstract] [Full Text] [Related]
48. [Recurrent jaundice in the course of natural and iatrogenic estrogen metabolism disorders]. Mach G; Gładysz A Pol Tyg Lek; 1979 Dec; 34(49):1923-4. PubMed ID: 94437 [TBL] [Abstract][Full Text] [Related]
49. [Contraceptives, application and side effects from the dermatological viewpoint]. Schäfer I Dtsch Gesundheitsw; 1971 Feb; 26(9):405-9. PubMed ID: 4104204 [No Abstract] [Full Text] [Related]
50. [Inhibitors of human ovulation. General principles and accumulated experiences with sequential therapy based on mestranol and chlormadinone acetate]. Zorrilla E Prensa Med Mex; 1968; 33(11):453-64. PubMed ID: 4105432 [No Abstract] [Full Text] [Related]
51. Chlormadinone acetate 0-5 mg. A report on its effectiveness in continuous use as an oral contraceptive. Christie GA Med J Aust; 1969 Jul; 2(4):185-9. PubMed ID: 4184973 [No Abstract] [Full Text] [Related]
52. [Hormone analytic studies during therapy with new contraceptive agents]. Tenhaeff D Geburtshilfe Frauenheilkd; 1971 Aug; 31(8):760-7. PubMed ID: 4105805 [No Abstract] [Full Text] [Related]
53. [Testing of an anti-conception drug: pure gestagen (chlormadinone acetate) in continually low dose]. Jeppsson S; Kullander S Lakartidningen; 1969 Sep; 66(39):3949-55. PubMed ID: 4192490 [No Abstract] [Full Text] [Related]
55. Significance of dysmenorrhea in infertility. Report of a preliminary study of therapy with a sequential estrogen-progestagen regimen. Roland M; Clyman M; Decker A; Ober WB Pac Med Surg; 1966; 74(3):135-8. PubMed ID: 4160710 [No Abstract] [Full Text] [Related]
56. [Clinical evaluation of the hormonal effect of ovosiston in various dosages]. Kühndel K; Ebeling K; Rothe K Z Arztl Fortbild (Jena); 1971 Jan; 65(2):79-84. PubMed ID: 4104626 [No Abstract] [Full Text] [Related]
57. [Effect of ovosiston on the thrombelastogram]. Sulek K; Grzeniewski L Ginekol Pol; 1972; 43(3):339-44. PubMed ID: 4112059 [TBL] [Abstract][Full Text] [Related]
58. [Dysfunctional uterine bleeding. Hormonal management with chlormadinone acetate]. Olivas Mendoza G; Santos Martínez A; Corral Olaguez M; Iduñate y Carlos DM; Hernández Ayup S Ginecol Obstet Mex; 1978 Dec; 44(266):463-71. PubMed ID: 84774 [TBL] [Abstract][Full Text] [Related]